Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley

Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley

Original Source

Read the full article at Finance →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.